Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.507
AS - Asia 4.092
EU - Europa 2.851
SA - Sud America 672
AF - Africa 118
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.381
SG - Singapore 1.545
CN - Cina 798
HK - Hong Kong 600
RU - Federazione Russa 566
DE - Germania 560
VN - Vietnam 546
BR - Brasile 483
IT - Italia 390
IE - Irlanda 325
SE - Svezia 300
GB - Regno Unito 160
FR - Francia 150
IN - India 128
AT - Austria 105
UA - Ucraina 85
AR - Argentina 72
CA - Canada 72
ID - Indonesia 65
KR - Corea 63
BD - Bangladesh 61
FI - Finlandia 49
IQ - Iraq 43
ZA - Sudafrica 41
PK - Pakistan 40
TR - Turchia 39
MX - Messico 34
JP - Giappone 33
EC - Ecuador 32
DK - Danimarca 29
CO - Colombia 26
PL - Polonia 25
SA - Arabia Saudita 24
ES - Italia 21
UZ - Uzbekistan 20
NL - Olanda 19
PH - Filippine 15
VE - Venezuela 15
BE - Belgio 14
EG - Egitto 13
PY - Paraguay 12
TN - Tunisia 12
CL - Cile 11
MY - Malesia 10
PE - Perù 10
AU - Australia 9
ET - Etiopia 8
TH - Thailandia 8
JO - Giordania 7
KE - Kenya 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
KG - Kirghizistan 6
SN - Senegal 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
LT - Lituania 5
MK - Macedonia 5
NG - Nigeria 5
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
EU - Europa 4
IR - Iran 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
UY - Uruguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BH - Bahrain 2
BJ - Benin 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
GR - Grecia 1
GY - Guiana 1
Totale 14.242
Salva come PNG Salva come JPEG
Città #
Ann Arbor 877
Singapore 854
Hong Kong 585
Ashburn 517
Fairfield 495
San Jose 450
Frankfurt am Main 414
Chandler 316
Dublin 313
Wilmington 257
Woodbridge 221
Houston 215
Seattle 208
New York 205
Dallas 179
Ho Chi Minh City 163
Dearborn 139
Milan 139
Beijing 136
Princeton 130
Cambridge 124
Hanoi 118
Chicago 117
Santa Clara 109
Los Angeles 108
The Dalles 108
Vienna 96
Hefei 81
Moscow 76
Jacksonville 73
Lauterbourg 69
Altamura 58
Lawrence 56
Seoul 56
Nanjing 50
Shanghai 46
Buffalo 45
São Paulo 44
Jakarta 41
Council Bluffs 37
San Diego 34
Dong Ket 33
Munich 30
Haiphong 28
London 27
Helsinki 25
Da Nang 24
Guangzhou 23
Lissone 23
Orem 23
Tokyo 23
Baghdad 22
Toronto 22
Atlanta 21
Boardman 20
Montreal 20
Andover 19
Salt Lake City 19
Nanchang 17
Tashkent 17
Warsaw 17
Brooklyn 15
Kunming 15
Jiaxing 14
San Francisco 14
Shenyang 14
Belo Horizonte 13
Mumbai 13
Rio de Janeiro 13
Brussels 12
Changsha 12
Chennai 12
Columbus 12
Nuremberg 12
Poplar 12
Tianjin 12
Denver 11
Johannesburg 11
Lahore 11
Jeddah 10
Jinan 10
Phoenix 10
Quito 10
Brasília 9
Cairo 9
Hebei 9
Manchester 9
Pune 9
Falls Church 8
Hangzhou 8
Lappeenranta 8
Turku 8
Addis Ababa 7
Bexley 7
Biên Hòa 7
Dhaka 7
Düsseldorf 7
Edmonton 7
Lachine 7
Lima 7
Totale 9.213
Salva come PNG Salva come JPEG
Nome #
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 336
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 321
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 311
Heart rate as cardiovascular risk factor 298
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 271
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 271
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 267
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 266
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 265
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 262
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 259
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 251
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 248
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 244
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 236
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 229
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 228
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 226
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 223
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 220
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 214
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 214
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 204
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 199
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 196
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 191
The role of carotid baroreceptor stimulation 191
Effects of Renal Denervation on Sympathetic Nervous System Activity 190
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 188
Baroreflex activation therapy systems: current status and future prospects 186
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 182
Obesity and Hypertension 179
Sympathetic Nervous System, Sleep, and Hypertension 176
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 176
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 173
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 173
The role of brain in neurogenic prehypertension 171
Blood pressure measurement, white-coat and masked hypertension 171
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 168
Elevated heart rate as sympathetic biomarker in human obesity 166
Sympatho-Vagal Imbalance in Hypertension 163
New-onset aortic dilatation in the population: a quarter-century follow-up 162
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 158
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 157
Heart rate as a predictor of cardiovascular risk 155
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 155
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 154
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 154
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 148
Lercanidipine in the management of hypertension: An update 148
Obesity and hypertension 148
Sleep Apnea and Hypertension 147
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 145
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 144
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 143
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 140
Device-Based Treatment in Hypertension and Heart Failure 139
Cigarette smoking and the adrenergic nervous system 138
Treatment of resistant hypertension 137
Clinical relevance of the sympathetic–vascular interactions in health and disease 137
Cardiovascular physiology: regulation of blood pressure 136
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 135
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 134
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 134
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 134
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 134
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 130
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 128
Neural Mechanisms 126
Baroreceptor Stimulation 126
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 122
Neurohormonal interactions 122
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 121
Sympathetic Activity in Hypertension and Heart Failure 116
Arterial alterations in hypertension 115
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 107
Microvascular Alterations in Obesity 106
Trained Athletes 105
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 103
Sympathomodulation in congestive heart failure: From drugs to devices 103
The sympathetic nervous system in hypertension 97
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 92
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 91
Totale 14.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 0 87 126
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20265.226 519 310 489 665 653 319 950 299 455 496 71 0
Totale 14.629